COLOPLAST-B (CBHD.DE) Stock Price, Forecast & Analysis
Europe - FRA:CBHD - DK0060448595 - Common Stock
CBHD.DE Key Statistics, Chart & Performance
The current stock price of CBHD.DE is 78.28 EUR. In the past month the price increased by 2.17%. In the past year, price decreased by -33.38%.
CBHD.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1EL.MI | ESSILORLUXOTTICA | 46.26 | 147.19B | ||
| ESL.DE | ESSILORLUXOTTICA | 46.2 | 147.00B | ||
| EL.PA | ESSILORLUXOTTICA | 46.19 | 146.96B | ||
| 2U3.DE | ALCON INC | 25.03 | 32.64B | ||
| AFW.DE | ALIGN TECHNOLOGY INC | 14.62 | 8.87B | ||
| GENT.OL | GENTIAN DIAGNOSTICS ASA | 20.52 | 851.18M | ||
| GBT.PA | GUERBET | 26.1 | 201.23M | ||
| ALCJ.PA | CROSSJECT | N/A | 125.09M | ||
| AFME.PA | AFFLUENT MEDICAL SA | N/A | 64.14M | ||
| SVS.MI | SVAS BIOSANA SPA | 7.72 | 54.88M | ||
| PTP.DE | PENTIXAPHARM HOLDING AG | N/A | 38.19M | ||
| IVN.MI | IVISION TECH SPA | N/A | 17.32M |
Related stock screener links
About CBHD.DE
Company Profile
Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.
Company Info
COLOPLAST-B
Holtedam 1-3
Humlebaek DK
Employees: 16628
Phone: 4549111111
COLOPLAST-B / CBHD.DE FAQ
What does COLOPLAST-B do?
Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.
What is the current price of CBHD stock?
The current stock price of CBHD.DE is 78.28 EUR. The price increased by 3.27% in the last trading session.
What is the dividend status of COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a dividend yield of 3.73%. The yearly dividend amount is currently 2.81.
What is the ChartMill technical and fundamental rating of CBHD stock?
CBHD.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists CBHD stock?
CBHD.DE stock is listed on the Deutsche Boerse Ag exchange.
Is COLOPLAST-B (CBHD.DE) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CBHD.DE.
What is the market capitalization of CBHD stock?
COLOPLAST-B (CBHD.DE) has a market capitalization of 16.45B EUR. This makes CBHD.DE a Large Cap stock.
CBHD.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CBHD.DE. When comparing the yearly performance of all stocks, CBHD.DE is a bad performer in the overall market: 92.24% of all stocks are doing better.
CBHD.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE. CBHD.DE has an excellent profitability rating, but there are concerns on its financial health.
CBHD.DE Financial Highlights
Over the last trailing twelve months CBHD.DE reported a non-GAAP Earnings per Share(EPS) of 2.55. The EPS decreased by -13.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.62% | ||
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| Debt/Equity | 1.05 |
CBHD.DE Forecast & Estimates
26 analysts have analysed CBHD.DE and the average price target is 92.76 EUR. This implies a price increase of 18.49% is expected in the next year compared to the current price of 78.28.
For the next year, analysts expect an EPS growth of -2.42% and a revenue growth 3.9% for CBHD.DE